Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis

被引：1

作者：

Augustin, Matthias ^{[1
,9
]}

Mrowietz, Ulrich ^{[2
]}

Willsmann-Theis, Dagmar ^{[3
]}

Gerdes, Sascha ^{[2
]}

Fotiou, Konstantinos ^{[4
]}

Schuster, Christopher ^{[4
,5
]}

Mert, Can ^{[6
]}

Holzkaemper, Thorsten ^{[4
]}

Behrens, Frank ^{[7
]}

Pinter, Andreas ^{[8
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf UKE, Inst Hlth Serv Res Dermatol & Nursing IVDP, German Ctr Hlth Serv Res Dermatol, Hamburg, Germany

[2] Univ Med Ctr Schleswig Holstein, Psoriasis Ctr, Dept Dermatol, Campus Kiel, Kiel, Germany

[3] Univ Hosp Bonn, Clin & Polyclin Dermatol & Allergol, Bonn, Germany

[4] Eli Lilly & Co, Indianapolis, IN USA

[5] Med Univ Vienna, Dept Dermatol, Vienna, Austria

[6] HaaPACS GmbH, Schriesheim, Germany

[7] Goethe Univ Frankfurt, Ctr Innovat Diagnost & Therapy Rheumatol Immunol, Frankfurt, Germany

[8] Univ Hosp Frankfurt, Dept Dermatol Venereol & Allergol, Frankfurt, Germany

[9] Univ Med Ctr Hamburg Eppendorf, German Ctr Hlth Serv Res Dermatol, Martinistr 52, D-20246 Hamburg, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2024年

关键词：

EFFICACY;

D O I：

10.1111/ddg.15292

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：4

共 50 条

[1] Nail psoriasis as a predictor of skin response to ixekizumab in patients with moderate-to-severe psoriasis
Rich, P.
Goldblum, O.
Amato, D.
Disch, D.
Muram, D.
Merola, J. F.
Elewski, B.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S67 - S67
[2] Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-To-Severe Psoriasis
Rich, Phoebe
Goldblum, Orin
Disch, Damon
Lin, Chen-Yen
Merola, Joseph F.
Elewski, Boni
JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (08) : 741 - 746
[3] Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium
Carmona-Rocha, Elena
Puig, Lluis
IMMUNOTHERAPY, 2023, 15 (15) : 1209 - 1225
[4] Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
Ren, Vicky
Dao, Harry, Jr.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2013, 6 : 75 - 80
[5] Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis
Zhou, Yi
Ding, Yantao
Cui, Mengxing
Zhang, Yuanjing
Wang, Mengwei
Zhou, Feiran
Su, Yi
Liang, Bo
Zhou, Fusheng
MEDICAL SCIENCE MONITOR, 2024, 30
[6] Ixekizumab is superior to placebo for the treatment of nail, scalp, and palmoplantar psoriasis in pediatric patients with moderate to severe plaque psoriasis
Paller, Amy S.
Magarinos, Gabriel Alejandro
Pinter, Andreas
Cather, Jennifer
Keller, Stuart
Capriles, Claudia Rodriguez
Gallo, Gaia
Edson-Heredia, Emily
Li, Lingnan
Papp, Kim
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB20 - AB20
[7] Indirect comparison of ixekizumab versus tildrakizumab for up to 12 weeks of treatment in patients with moderate-to-severe psoriasis
Gottlieb, Alice
Saure, Daniel
Wilhelm, Stefan
Dossenbach, Martin
Thaci, Diamant
Smith, Saxon D.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB82 - AB82
[8] Indirect comparison of ixekizumab versus risankizumab for up to 12 weeks of treatment in patients with moderate-to-severe psoriasis
Gottlieb, Alice B.
Ramot, Yuval
Smith, Saxon D.
Saure, Daniel
Schuster, Christopher
Schacht, Alexander
Thaci, Diamant
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB226 - AB226
[9] A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Kirkham, Bruce W.
Egeberg, Alexander
Behrens, Frank
Pinter, Andreas
Merola, Joseph F.
Holzkaemper, Thorsten
Gallo, Gaia
Ng, Khai Jing
Bolce, Rebecca
Schuster, Christopher
Nash, Peter
Puig, Luis
RHEUMATOLOGY AND THERAPY, 2023, 10 (05) : 1127 - 1146
[10] Efficacy of ixekizumab on nail psoriasis in paediatric patients with moderate-to-severe psoriasis: a post hoc analysis from IXORA-PEDS
Seyger, M. M. B.
Reich, A.
El Baou, C.
Schuster, C.
Riedl, E.
Paller, A. S.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (12) : E911 - E913

← 1 2 3 4 5 →